MyFinsight
Home
Blog
About
Contact
Download
Download image
Prepaid expenses and
other current assets
$75,596K
Inventory
$21,686K
Trade receivables,
net
$286,916K
Marketable securities
$576,603K
Cash and cash
equivalents
$482,488K
Right-of-use assets and other
non-current assets
$342,305K
Goodwill
$63,684K
Deferred tax assets, net
$292,582K
Property and equipment,
net
$98,960K
Non-current marketable
securities
$603,603K
Total current assets
$1,443,289K
Total assets
$2,844,423K
Total liabilities and
stockholders equity
$2,844,423K
Total stockholders
equity
$2,161,319K
Total liabilities
$683,104K
Accumulated deficit
-$76,830K
Accumulated other
comprehensive income (loss)
$3,476K
Additional
paid-in-capital
$2,234,411K
Other non-current
liabilities
$104,422K
Non-current operating lease
liabilities
$173,038K
Total current
liabilities
$405,644K
Common stock, 0.001 par
value 400,000 shares...
$262K
Other current
liabilities
$125,382K
Accrued collaboration
liabilities
$22,783K
Rebates and fees due to
customers
$59,896K
Accrued clinical trial
liabilities
$65,742K
Accrued compensation
and benefits
$102,218K
Accounts payable
$29,623K
Back
Back
Balance Sheet
source: myfinsight.com
Exelixis-Logo-2023-svg
EXELIXIS, INC. (EXEL)
Exelixis-Logo-2023-svg
EXELIXIS, INC. (EXEL)